Leicester City Clinical Commissioning Group (CCG) is in the process of finalising the structure for the Primary Care Networks (PCNs) in Leicester with general practitioner practices. PCNs are agreed for the majority of practices in the area. It is expected that confirmation for the remaining small number of practices not yet signed up will be given before the deadline of 30 June. As soon as the full structure is agreed, it will be communicated with the Leicester population and stakeholders. The CCG\u2019s expectation is that all practices will be part of a PCN.<\/p>
<\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-19T14:27:53.127Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Practitioners: Leicester"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many GP practices in Leicester have joined the NHS Primary Care Network.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/338", "label" : {"_value" : "Biography information for Keith Vaz"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester East"}
, "tablingMemberPrinted" : [{"_value" : "Keith Vaz"}
], "uin" : "263694"}
, {"_about" : "http://data.parliament.uk/resources/1131849", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1131849/answer", "answerText" : {"_value" : " The NHS Long Term Plan sets out plans to improve early cancer diagnosis, and a new ambition that, by 2028, the proportion of cancers diagnosed at stages one and two will rise from around half to three-quarters of cancer patients. This will be achieved through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment, maximising the number of cancers that are identified through screening, and harnessing new innovations in technology. A radical overhaul of the way diagnostic services are delivered will ensure that people can get their diagnosis more quickly, including the roll-out of new Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise.<\/p> <\/p> The independent cancer taskforce recommended the introduction of a new faster diagnosis standard to ensure that people receive a life changing confirmation of whether or not they have cancer within 28 days. This proposed new standard is being considered as part of the clinical review of National Health Service access standards currently being undertaken by NHS England.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-19T14:26:47.083Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to improve NHS waiting times for cancer patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
, "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
], "uin" : "263683"}
, {"_about" : "http://data.parliament.uk/resources/1131187", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1131187/answer", "answerText" : {"_value" : " The United Kingdom participates in various transparency initiatives, including the European Integrated Price Information Database, the World Health Organization\u2019s Pharmaceutical Pricing Reimbursement Information Network, and the Global Fund Price and Quality Database. The UK has a long-established and globally-recognised track record of assessing the price of new, innovative medicines according to their clinical value, rather than pricing by their development costs or international reference prices.<\/p> We believe that is the right approach: ensuring the development of the best medicines in areas of high unmet need are rewarded. The Government could not, therefore, agree to a resolution which had the potential to increase medicines prices and reduce patient access, by reducing the ability of the National Health Service to undertake commercial negotiations with pharmaceutical companies on the price of new medicines.<\/p> The approach taken by the NHS has meant we were the first country in Europe to offer innovative CAR-T therapies, alongside many other new medicines.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-19T14:20:00.42Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the UK Government\u2019s response to the resolution on improving the transparency of markets at the 72nd World Health Assembly in Geneva on the ability of people in the UK to access medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4653", "label" : {"_value" : "Biography information for Stephen Morgan"}
}
, "tablingMemberConstituency" : {"_value" : "Portsmouth South"}
, "tablingMemberPrinted" : [{"_value" : "Stephen Morgan"}
], "uin" : "263223"}
, {"_about" : "http://data.parliament.uk/resources/1131208", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1131208/answer", "answerText" : {"_value" : " The vast majority of medicines are not subject to supply problems and every day over 2 million prescription items are successfully dispensed in England.<\/p> Where problems do occur the Department\u2019s Medicines Supply Team has well established procedures to deal with medicine shortages and works closely with all stakeholders to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.<\/p> We are aware of ongoing supply issues with the Adalat range of the drug nifedipine due to manufacturing capacity constraints. We have been working closely with all suppliers of generic and other brands of nifedipine to maintain overall supply of this medicine to patients and have provided regular updates about the situation to the National Health Service.<\/p> We will continue to work closely with all manufacturers of nifedipine preparations to monitor the overall supply situation to ensure supplies continue to remain available.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-19T14:22:30.34Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle shortages of (a) Adalat, (b) Nifedipine and (c) other common medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4637", "label" : {"_value" : "Biography information for James Frith"}
}
, "tablingMemberConstituency" : {"_value" : "Bury North"}
, "tablingMemberPrinted" : [{"_value" : "James Frith"}
], "uin" : "263235"}
, {"_about" : "http://data.parliament.uk/resources/1131255", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1131255/answer", "answerText" : {"_value" : "